Rocuronium for rapid sequence intubation of emergency department patients

John C. Sakles, Erik G Laurin, Aaron A. Rantapaa, Edward A Panacek

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Rocuronium is a recently synthesized non-depolarizing neuromuscular blocking agent (NMBA) that has been demonstrated to have a faster onset of action than any other non-depolarizing NMBA. Although widely studied in the operating room, there are no reports regarding its use for emergent tracheal intubation in the emergency department (ED). The purpose of this study was to evaluate the use of rocuronium for rapid sequence intubation (RSI) in ED patients. An intubation data collection form was completed prospectively for any patient receiving rocuronium for RSI in the ED from July 1-December 31, 1997. Two hundred eighty-eight patients were intubated in the ED over this six-month period, of whom 261 (91%) underwent RSI. Fifty-eight of the patients undergoing RSI received rocuronium for paralysis (22%). The most common reason reported for use of rocuronium was a concern regarding hyperkalemia (53%). The mean dose used was 1.0 ± 0.2 mg/kg. The mean onset to paralysis was 45 ± 15 s. Of the complications reported, none appeared to be related to rocuronium. Use of rocuronium in the ED setting appears useful.

Original languageEnglish (US)
Pages (from-to)611-616
Number of pages6
JournalJournal of Emergency Medicine
Volume17
Issue number4
DOIs
StatePublished - 1999

Fingerprint

Intubation
Hospital Emergency Service
Neuromuscular Blocking Agents
Paralysis
Hyperkalemia
Operating Rooms
rocuronium

Keywords

  • Emergency department intubations
  • Neuromuscular blocking agent
  • Rapid sequence intubation
  • Rocuronium
  • Succinylcholine

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Rocuronium for rapid sequence intubation of emergency department patients. / Sakles, John C.; Laurin, Erik G; Rantapaa, Aaron A.; Panacek, Edward A.

In: Journal of Emergency Medicine, Vol. 17, No. 4, 1999, p. 611-616.

Research output: Contribution to journalArticle

@article{a9649574e7d444e8a5819676b5e833f9,
title = "Rocuronium for rapid sequence intubation of emergency department patients",
abstract = "Rocuronium is a recently synthesized non-depolarizing neuromuscular blocking agent (NMBA) that has been demonstrated to have a faster onset of action than any other non-depolarizing NMBA. Although widely studied in the operating room, there are no reports regarding its use for emergent tracheal intubation in the emergency department (ED). The purpose of this study was to evaluate the use of rocuronium for rapid sequence intubation (RSI) in ED patients. An intubation data collection form was completed prospectively for any patient receiving rocuronium for RSI in the ED from July 1-December 31, 1997. Two hundred eighty-eight patients were intubated in the ED over this six-month period, of whom 261 (91{\%}) underwent RSI. Fifty-eight of the patients undergoing RSI received rocuronium for paralysis (22{\%}). The most common reason reported for use of rocuronium was a concern regarding hyperkalemia (53{\%}). The mean dose used was 1.0 ± 0.2 mg/kg. The mean onset to paralysis was 45 ± 15 s. Of the complications reported, none appeared to be related to rocuronium. Use of rocuronium in the ED setting appears useful.",
keywords = "Emergency department intubations, Neuromuscular blocking agent, Rapid sequence intubation, Rocuronium, Succinylcholine",
author = "Sakles, {John C.} and Laurin, {Erik G} and Rantapaa, {Aaron A.} and Panacek, {Edward A}",
year = "1999",
doi = "10.1016/S0736-4679(99)00046-3",
language = "English (US)",
volume = "17",
pages = "611--616",
journal = "Journal of Emergency Medicine",
issn = "0736-4679",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Rocuronium for rapid sequence intubation of emergency department patients

AU - Sakles, John C.

AU - Laurin, Erik G

AU - Rantapaa, Aaron A.

AU - Panacek, Edward A

PY - 1999

Y1 - 1999

N2 - Rocuronium is a recently synthesized non-depolarizing neuromuscular blocking agent (NMBA) that has been demonstrated to have a faster onset of action than any other non-depolarizing NMBA. Although widely studied in the operating room, there are no reports regarding its use for emergent tracheal intubation in the emergency department (ED). The purpose of this study was to evaluate the use of rocuronium for rapid sequence intubation (RSI) in ED patients. An intubation data collection form was completed prospectively for any patient receiving rocuronium for RSI in the ED from July 1-December 31, 1997. Two hundred eighty-eight patients were intubated in the ED over this six-month period, of whom 261 (91%) underwent RSI. Fifty-eight of the patients undergoing RSI received rocuronium for paralysis (22%). The most common reason reported for use of rocuronium was a concern regarding hyperkalemia (53%). The mean dose used was 1.0 ± 0.2 mg/kg. The mean onset to paralysis was 45 ± 15 s. Of the complications reported, none appeared to be related to rocuronium. Use of rocuronium in the ED setting appears useful.

AB - Rocuronium is a recently synthesized non-depolarizing neuromuscular blocking agent (NMBA) that has been demonstrated to have a faster onset of action than any other non-depolarizing NMBA. Although widely studied in the operating room, there are no reports regarding its use for emergent tracheal intubation in the emergency department (ED). The purpose of this study was to evaluate the use of rocuronium for rapid sequence intubation (RSI) in ED patients. An intubation data collection form was completed prospectively for any patient receiving rocuronium for RSI in the ED from July 1-December 31, 1997. Two hundred eighty-eight patients were intubated in the ED over this six-month period, of whom 261 (91%) underwent RSI. Fifty-eight of the patients undergoing RSI received rocuronium for paralysis (22%). The most common reason reported for use of rocuronium was a concern regarding hyperkalemia (53%). The mean dose used was 1.0 ± 0.2 mg/kg. The mean onset to paralysis was 45 ± 15 s. Of the complications reported, none appeared to be related to rocuronium. Use of rocuronium in the ED setting appears useful.

KW - Emergency department intubations

KW - Neuromuscular blocking agent

KW - Rapid sequence intubation

KW - Rocuronium

KW - Succinylcholine

UR - http://www.scopus.com/inward/record.url?scp=0033168721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033168721&partnerID=8YFLogxK

U2 - 10.1016/S0736-4679(99)00046-3

DO - 10.1016/S0736-4679(99)00046-3

M3 - Article

C2 - 10431949

AN - SCOPUS:0033168721

VL - 17

SP - 611

EP - 616

JO - Journal of Emergency Medicine

JF - Journal of Emergency Medicine

SN - 0736-4679

IS - 4

ER -